Cancer Researcher in a Lifelong Quest (Thailand)
This article was originally published in PharmAsia News
Dr. Arkom Cheirsilpa was recently honored with the Eminent Scientist 2007 Asia Award for his work in cancer prevention and treatment. Dr. Cheirsilpa is currently the deputy director for Thailand's National Cancer Institute (NCI). His award-winning efforts have focused on encouraging the wider use of inexpensive chemotherapy alternatives. Thanks to his research, Thai cancer patients have better access to a number of low-cost, cancer-fighting drugs that also offer fewer side-effects. Cheirsilpa has also done much to help the NCI better educate the country about cancer prevention and early detection. The Eminent Scientist Asia Award is presented annually by the International Research Promotion Council, a UK-based organization dedicated to furthering scientific advances in developing Asia-Pacific nations. (Click here for more
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.